Announced on Thursday, the Master Supply Agreement, effective January 29, 2025, will enable Sonoma to distribute its Microcyn® technology-based products to major retailers across the United States.

BOULDER, CO / ACCESS Newswire / March 10, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...

Amy Trombly, CEO of Sonoma, stated that the registration with the MHRA allows the company to introduce its Microcyn-based products to the UK, highlighting the significance of this new market for ...

BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized ...

Amy Trombly, CEO of Sonoma, stated that the registration with the MHRA allows the company to introduce its Microcyn-based products to the UK, highlighting the significance of this new market for their ...